Overall, we evaluated the immunohistochemical expression of LY6G6D in (n = 334) colorectal cancer tissues consisting of 51 (15%) mucinous and 283 (85%) non-mucinous adenocarcinomas, respectively. Here, LY6G6D is linked to colon mucinous adenocarcinoma.